CYNTHIA GARCIA: Open Payments
NPI 1689249666 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,894 in 148 payments from 12 companies in 2025. Trend: 2023 $2,637 · 2024 $2,983 · 2025 $2,894
Food & beverage: $2,891Education: $4
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 27 | $490 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $332 |
| Neurocrine BioSciences, Inc. | 19 | $308 |
| E.R. Squibb & Sons, L.L.C. | 13 | $306 |
| Axsome Therapeutics, Inc. | 10 | $258 |
| ABBVIE INC. | 13 | $249 |
| Otsuka America Pharmaceutical, Inc. | 15 | $232 |
| Alkermes, Inc. | 9 | $194 |
| Janssen Pharmaceuticals, Inc | 7 | $183 |
| Lundbeck LLC | 7 | $167 |
Products named: UZEDY, CAPLYTA, INGREZZA, COBENFY, Auvelity, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
